The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirinJoseph A. Jakubowski, Andrew L. Frelinger, Marc R. Barnard et al.|Thrombosis and Haemostasis|2007Cited by 48
P2Y <sub>12</sub> Receptor Blockade Augments Glycoprotein IIb‐IIIa Antagonist Inhibition of Platelet Activation, Aggregation, and Procoagulant ActivityMichelle A. Berny‐Lang, Andrew L. Frelinger, Joseph A. Jakubowski et al.|Journal of the American Heart Association|2013Cited by 19
Abstract 3293: The Active Metabolite of Prasugrel Inhibits Platelet Procoagulant ActivitiesAndrew L. Frelinger, Alan D. Michelson, Joseph A. Jakubowski et al.|Circulation|2006Cited by 0